THRs influence the NF-κB pathway by interacting with the IKK complex, reducing the activation of NF-κB and the downstream expression of inflammatory cytokines, which are elevated in liver diseases like MASLD and MASH [159]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.